Calcimedica (CALC)CEO bought ~$75K

~$75K

Approx. value · 20K sh @ $3.75

131K

Holds after · shares reported

Traded

Nov 1, 2024

Filed

Nov 1, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 17, 2023InsiderDirector purchased ~$8K of CALC shares in the open market
2. Nov 1, 2024 · this disclosureInsiderCEO purchased ~$75K of CALC shares in the open market

What came next

1. Nov 1, 2024Insider · 4 peopleInsiders: 7 purchases (~$1.1M)
2. Dec 6, 2024InsiderDirector purchased ~$13K of CALC shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Calcimedica

OQRO holds no insider, Congress, fund or contract record for Calcimedica dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CALC page.

Other recent filings by A. Rachel Leheny, CHIEF EXECUTIVE OFFICER

• SEC Form 4 at Calcimedica (CALC)Jul 21, 2025
• SEC Form 4 at Calcimedica (CALC)Jul 16, 2025

The full history of A. Rachel Leheny, CHIEF EXECUTIVE OFFICER is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Calcimedica

• SEC Form 4Jun 29, 2026
• SEC Form 4Sep 22, 2025
• SEC Form 4Sep 17, 2025
• SEC Form 4Sep 15, 2025
• SEC Form 4Sep 11, 2025
• SEC Form 4Sep 2, 2025

Everything OQRO holds on this company is on its CALC page.